Biologics

While Health Canada's regulatory system has not proven stem cell procedures, patients continue to seek out private clinics to have the experimental treatments performed, according to CDC News.

National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Numerate a grant.

Here are 65-plus spine surgeons who are participating in clinical trials or have a research focus on biologics and/or stem cells for spine surgery.

The global stem cells market is slated to hit $270.5 billion by 2025, according to a Transparency Market Research report.

Global Stem Cells Groups teamed up with Aesthetic Polyclinic.

Golden-based Colorado Pain Care is now providing stem cell therapy to patients.

In August, FDA Commissioner Scott Gottlieb, MD, issued a statement on how the agency will enforce oversight of the stem cell industry moving forward. Dr. Gottlieb noted the FDA is ramping up efforts to prevent dishonest players in the field…

Amgen is investing in Fortuna Fix, a Canadian stem cell company, according to Endpoints News.

A new study published in Clinical Spine Surgery compares posterior cervical spine complications among patients who receive recombinant human bone morphogenetic protein-2 and those who do not.

The spine biologics global market is anticipated to grow at a 2.07 percent compound annual growth rate through 2020, according to a 360 Market Updates report.